Clinical Trial Update: Decitabine Plus mBU/CY Preconditioning for Relapse/Refractory Acute Leukemia [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on decitabine combined with mBU/CY preconditioning for relapse/refractory acute leukemia in Phase 2/Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Relapse Leukemia
• Stem Cell Transplant Complications

Drugs mentioned

• Decitabine (Decitabine)
• mBU/CY

Snippet

Sponsor: Peking University People's Hospital | Conditions: Stem Cell Transplant Complications, Relapse Leukemia | Phase 2, Phase 3 | Status: UNKNOWN